个人简介
在美国约翰霍普金斯大学获得博士学位并完成博士后研究。主要研究方向为心血管代谢性疾病流行病学。在国际学术期刊发表SCI论文30余篇，其中以第一作者（含共同第一作者）身份在Circulation、Annals of Internal Medicine等高影响力期刊发表多篇论文。
教学工作
研究生课程《流行病学1》
近期10篇代表性成果
# indicates co-first or co-last authors.
1. Xu Y, Chang AR, Inker LA, McAdams-DeMarco M, Grams ME, Shin JI. Associations of Apixaban Dose With Safety and Effectiveness Outcomes in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease. Circulation. 2023 Nov 7;148(19):1445-1454.
2. Xu Y, Shin JI, Wallace A, Carrero JJ, Inker LA, Mukhopadhyay A, Blecker SB, Horwitz LI, Grams ME, Chang AR. Shortfalls in Follow-up Albuminuria Quantification After an Abnormal Result on a Urine Protein Dipstick Test. Ann Intern Med. 2024 Nov;177(11):1593-1595.
3. Xu Y, Carrero JJ, Chang AR, Inker LA, Zhang D, Mukhopadhyay A, Blecker SB, Horwitz LI, Grams ME, Shin JI. Titration and Discontinuation of Semaglutide for Weight Management in Commercially Insured US Adults. Obesity (Silver Spring). 2025 Jul;33(7):1243-1248.
4. Xu Y, Echouffo Tcheugui JB, Coresh J, Grams ME, Selvin E, Fang M, Shin JI. Trends in Obesity and Glucagon-Like Peptide-1 Receptor Agonist Prescriptions in Type 1 Diabetes in the United States. Diabetes Obes Metab. 2025 Jun;27(6):2967-2976.
5. Xu Y, Ballew SH, Chang AR, Inker LA, Grams ME, Shin JI. Risk of Major Bleeding, Stroke/Systemic Embolism, and Death Associated With Different Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease. J Am Heart Assoc. 2024 Aug 20;13(16):e034641.
6. Xu Y, Boyle TA, Lyu B, Ballew SH, Selvin E, Chang AR, Inker LA, Grams ME, Shin JI. Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Atrial Fibrillation in Adults With Diabetes: A Real-World Study. J Gen Intern Med. 2024 May;39(7):1112-1121.
7. Sandokji I#, Xu Y#, Denburg M, Furth S, Abraham AG#, Greenberg JH#. Current and Novel Biomarkers of Progression Risk in Children With Chronic Kidney Disease. Nephron. 2024;148(1):1-10.
8. Xu Y, Chang AR, Inker LA, McAdams-DeMarco M, Grams ME, Shin JI. Concomitant Use of Diltiazem With Direct Oral Anticoagulants and Bleeding Risk in Atrial Fibrillation. J Am Heart Assoc. 2022 Jul 19;11(14):e025723.
9. Bosi A#, Xu Y#, Gasparini A, Wettermark B, Barany P, Bellocco R, Inker LA, Chang AR, McAdams-DeMarco M, Grams ME, Shin JI#, Carrero JJ#. Use of Nephrotoxic Medications in Adults With Chronic Kidney Disease in Swedish and US Routine Care. Clin Kidney J. 2021 Oct 29;15(3):442-451.
10. Xu Y, Ng DK, Furth SL, Warady BA, Mitsnefes MM. Factors Associated With the Absence of Pharmacological Treatment for Common Modifiable Complications in Children With Chronic Kidney Disease. Pediatr Nephrol. 2021 Oct;36(10):3181-3189.
